Skip to content

TRIAL FOR USE OF LOCAL ANAESTHETIC AGENT IN LAPAROSCOPIC GYNAECOLOGICAL SURGERIES FOR REDUCING POST OPERATIVE PAIN

A randomised control trial to evaluate the efficacy and safety of port site and intraperitoneal infiltration of bupivacaine for reducing post operative pain in laparoscopic gynaecological surgeries - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/05/008664
Enrollment
100
Registered
2017-05-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- all patients undergoing gynaecological operative procedures

Interventions

Intervention1: bupivacaine: intraperitoneal and skin infiltration with 0.125 % Bupivacaine, 30 ml at the end of laparoscopic operative gynaecological procedure and recording pain scores in post operat

Sponsors

Armed Forces Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA status I & II All cases of Operative laparoscopic gynaecological surgeries

Exclusion criteria

Exclusion criteria: Laparoscopic Gynaecological Oncology surgeries history of opiod use/ alcohol abuse in last 24 hours prior to study Weight history of allergy to the drug in study Chronic Pain Syndrome

Design outcomes

Primary

MeasureTime frame
1.To evaluate the efficacy of port site and intraperitoneal Bupivacaine in reducing post operative pain by comparing VAS scores between intervention and control armTimepoint: 2 hour, 4hours and 8 hours post operatively

Secondary

MeasureTime frame
1.To evaluate the safety and note the side effects if any of port site and intraperitoneal Bupivacaine used for reducing post operative pain 2.To compare the need for rescue analgesia between the intervention and control armTimepoint: 2 hour, 4hours and 8 hours post operatively

Countries

India

Contacts

Public ContactSqn Ldr Isha Bansal

Armed Forces Medical College

docatulseth@yahoo.com8390433228

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026